AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03868605 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMR and ESD
Description: Endoscopic mucosal resection using a resection snare Endoscopic submucosal dissection using an electrosurgical knife
Study NCT03868605 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Over- the- scope full- thickness resection device
Description: Endoscopic resection of neoplastic lesions of the colon using the over- the- scope full- thickness resection device
Study NCT02926404 — intervention group
Intervention type: DEVICE
Intervention: UNiD Rods
Description: Spinal osteosynthesis
Study NCT01330173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vismodegib
Description: Given PO
Study NCT01330173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT01330173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02776384 — intervention group
Intervention type: OTHER
Intervention: Observational study
Study NCT01582685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.
Study NCT03154073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise Training (MOD)
Description: For the first 4 weeks, participant will be asked to complete 3 days of exercise/week at 50-65% heart rate maximum. Sessions will last between 30-40 minutes excluding the warm-up and cool down (5-10 minutes). After 4 weeks, the MOD group will be expected to match the exercise prescription. The exercise prescription for the MOD group for weeks 5-12 will be 4 days/week, 45 min/session completed at 60-65% heart rate maximum.
Study NCT03154073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vigorous Intensity Exercise Training (VIG)
Description: The exercise lead in period will be the same as the moderate intensity exercise training program. After 6 weeks, the VIG group will be expected to match the exercise prescription. The exercise prescription for the VIG for weeks 7-12 will be 4 days/week, 45 min/session completed at 80-85% heart rate maximum.
Study NCT03866473 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Retilux
Description: 670nm wavelength light
Study NCT03866473 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Light Device
Description: Broad spectrum light device
Study NCT00682773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SBAR
Description: Educational intervention for nursing staff on effective communication regarding warfarin treatment/care; use of SBAR communication forms.
Study NCT01049932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMC278LA
Description: TMC278LA 600mg injected intramuscularly (i/m)
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual RBT (t-RBT)
Description: Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social Club Job Club
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced RBT (r-RBT)
Description: Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Abbreviated RBT (a-RBT)
Description: Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced RBT (e-RBT)
Description: Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job Club Recovery housing CAP housing admission Recovery sponsor
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Early compliant t-RBT
Description: r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social club Job club
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early non-compliant t-RBT
Description: t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Early non-compliant t-RBT
Description: t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early compliant r-RBT
Description: a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Early compliant r-RBT
Description: a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
Study NCT01177982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early non-compliant r-RBT
Description: r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social Club Job Club
Study NCT05131568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Layered thermal insulation system
Description: No other intervention
Study NCT02637570 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hibiscus tea
Study NCT02637570 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Hibiscus tea
Study NCT02637570 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: green tea
Study NCT02637570 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: green tea
Study NCT02637570 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: placebo (dextrose)
Study NCT01165931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat (BAY63-2521)
Description: 0.1 mg intracoronary infusion through coronary guide catheter. Single dose. Sequential application after initial vasoactive bolus of Adenosine (non-study drug) and Nitroglycerin (non-study drug).
Study NCT00657202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Description: Given as an injection into three cutaneous neurofibromas on day 1 of the study treatment.
Study NCT01281969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gamunex Intravenous Immunoglobulin
Description: 2.0 gm/kg total, IV (in the vein), over 2 days
Study NCT01281969 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline, IV (in the vein), over 2 days
Study NCT04688073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Running
Study NCT04688073 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Rest
Description: sit and rest
Study NCT03525431 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Whole Exome Sequencing
Description: Whole Exome Sequencing is a form of Next Generation Sequencing allowing investigators to assess the coding regions of many thousands of genes to find variants implicated in disease.
Study NCT03929757 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV
Description: Participants will receive 0.5 mL IM injection of Ad26.ZEBOV as first vaccination.
Study NCT03929757 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo
Description: Participants will receive 0.5 mL IM injection of MVA-BN-Filo as second vaccination.
Study NCT03929757 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MenACWY
Description: Participants will receive 0.5 mL IM injection of MenACWY.
Study NCT03929757 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MenACWY
Description: Participants will receive 0.5 mL IM injection of MenACWY.
Study NCT02457169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Preschool Engagement intervention
Description: This 1-2 session intervention (2-4 hours total) will involve one-on-one session(s) for parents whose children (all of whom have received a diagnosis of ASD through our study) are turning 3 and therefore transitioning from the Early Intervention system to the public school special education system. The intervention will utilize motivational interviewing (MI) principles to equip parents with the skills, knowledge, and clarity of goals necessary to collaborate effectively with school special education staff and teachers, to advocate for their children's needs, and to be empowered to navigate the special education system.
Study NCT02457169 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Attention Control
Description: The attention control condition is parallel in format (one-on-one between parent with interventionist) and intensity (1-2 sessions, or 2-4 hours total). It involves open-ended interviews with parents about their child's development and plans for school.
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vitamin D oral gel
Description: vitamin D is a fat soluble vitamin which has important calcemic roles in the body regarding bone homeostasis and calcium/phosphorus balance. Recently, the non-calcemic roles of vitamin D as anti-inflammatory, anti-oxidant and immuno-regulatory functions have been widely reported.So, we tried to use it for prevention of radiation induced oral mucositis
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miconazole Topical Gel
Description: topical anti fungal agent
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Miconazole Topical Gel
Description: topical anti fungal agent
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBC oral spray
Description: Topical anesthetics and anti-inflammatory agent
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BBC oral spray
Description: Topical anesthetics and anti-inflammatory agent
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oracure gel
Description: Topical analgesic gel
Study NCT04308161 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oracure gel
Description: Topical analgesic gel
Study NCT04308161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alkamisr sachets
Description: Sodium bicarbonate mouthwash
Study NCT04308161 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alkamisr sachets
Description: Sodium bicarbonate mouthwash
Study NCT02743026 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FOXY
Description: This study will evaluate an arts-based HIV prevention program, Fostering Open eXpression among Youth (FOXY) in the NWT, Canada that works with Northern and Indigenous youth to promote sexual health and reduce exposure to HIV/STI. FOXY explores sexual health, HIV/STIs, sexuality and healthy relationships with young women in the NWT. The program's goal is to use arts-based methods and peers to facilitate education and foster more open expression and communication regarding sexual health and sexuality. FOXY uses arts-based approaches in program delivery; for example, drama techniques are used to facilitate discussion and learning about healthy relationships and making positive choices in realistic sexual scenarios.
Study NCT02035644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jinlida granules